Lactate‐Depleting Nanotherapy Reprograms the Immunometabolic Microenvironment to Overcome Biofilm Tolerance in Implant‐Associated Infections
Advanced Materials · 2026
DOI: 10.1002/adma.75214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Wenbo Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Shanghai Institute of Microsurgery on Extremities, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Ton…. Hauptthemen laut MEDLINE: Biofilms, Lactic Acid, Prostheses and Implants, Nanomedicine. Die Arbeit nennt 68 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Biofilm formation in implant‐associated infections (IAIs) establishes an immunosuppressive microenvironment while conferring profound antibiotic tolerance. Through multi‐omics profiling of clinical IAI samples, we identify lactate as a key metabolite associated with immunosuppression within the biofilm‐associated microenvironment of IAIs. Guided by this insight, we engineer a nanotherapeutic platform (LMVM) comprising vacancy‐engineered hollow magnetite nanoparticles (VE‐HMN) coloaded with lactate oxidase (LOX) and metronidazole (MNZ). By depleting lactate, LMVM remodels the immunosuppressive microenvironment and restores antimicrobial immunity, thereby highlighting lactate as an immunometabolic regulator in biofilm‐associated infections. Simultaneously, lactate oxidation intensifies local hypoxia, which redirects bacterial metabolism to activate MNZ against tolerant subpopulations while suppressing staphyloxanthin (STX)‐dependent antioxidant defenses. As a result, this immunometabolism‐guided nanotherapy achieves robust biofilm eradication in murine IAI models and promotes tissue repair. Collectively, these findings identify lactate‐mediated immunosuppression as a therapeutically actionable feature of biofilm‐associated infections and support a clinically guided materials strategy that couples immunometabolic microenvironment remodeling with the eradication of antibiotic‐tolerant biofilms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Shanghai Institute of Microsurgery on Extremities, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Oncology, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou, China.
- Department of Orthopedic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Center For Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Biyu Rui, Zesong Ruan, Yingying Huang, Yunfeng Chen
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, W., Rui, B., Wang, G., Ruan, Z., Luo, Z., Zhang, Y., Shi, T., Huang, Y., & Chen, Y. (2026). Lactate‐Depleting Nanotherapy Reprograms the Immunometabolic Microenvironment to Overcome Biofilm Tolerance in Implant‐Associated Infections. Advanced Materials. https://doi.org/10.1002/adma.75214
Vancouver
Wang W, Rui B, Wang G, Ruan Z, Luo Z, Zhang Y, et al. Lactate‐Depleting Nanotherapy Reprograms the Immunometabolic Microenvironment to Overcome Biofilm Tolerance in Implant‐Associated Infections. Advanced Materials. 2026. doi:10.1002/adma.75214
BibTeX
@article{Wang2026,
author = {Wang, Wenbo and Rui, Biyu and Wang, Guixia and Ruan, Zesong and Luo, Zhiyuan and Zhang, Yunlong and Shi, Tingwang and Huang, Yingying and Chen, Yunfeng},
title = {Lactate‐Depleting Nanotherapy Reprograms the Immunometabolic Microenvironment to Overcome Biofilm Tolerance in Implant‐Associated Infections},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.75214}
}
EUVIMED